Company Overview: Knight Therapeutics Inc. (TSX: GUD) is a specialty and generic pharmaceutical company focused on the development, acquisition, in-licensing, out-licensing, marketing, and distribution of innovative prescription medicines, consumer health products, and medical devices across Canada and selected international markets. This Report covers Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendation on this one stock.
Canada Market Round-Up
The S&P/TSX Composite Index ended last week on a strong note, gaining 1.86% to 33,073.71 and extending its positive momentum into February 13, 2026. Gains were broad-based, led by basic materials, technology, healthcare, industrials, energy, real estate, consumer cyclicals, utilities, and financials, signalling a healthy improvement in risk appetite across both cyclical and defensive sectors. Weakness in consumer non-cyclicals, however, modestly capped the overall advance. From a technical perspective, the index continues to exhibit a firm bullish structure. Prices remain comfortably above the rising trendline support and the 21-period SMA, reinforcing the prevailing uptrend and suggesting sustained buying interest on pullbacks. Immediate resistance is seen near 33,600, where a decisive breakout could unlock further upside. On the downside, key support lies around 32,400; a sustained break below this level could trigger a short-term corrective pullback. The weekly RSI at 70.86 highlights strong momentum, though overbought conditions suggest the potential for near-term consolidation or profit-taking before the next leg higher.
On the macro front, the upcoming major economic events that may impact the Canadian market sentiment include CA CPI m/m, US FOMC Meeting Minutes and US Unemployment Claims.
Global Markets Wrap-Up
U.S. equity markets ended the week lower on February 13, 2026, as cautious investor sentiment weighed on risk appetite across major benchmarks. The Nasdaq Composite was the clear underperformer, declining 2.11% to 22,546.67, reflecting renewed pressure on growth and technology stocks. The Russell 2000 also showed relative weakness, easing 0.88% to 2,646.70, despite selective strength in certain small-cap names. On the macro front, data from the U.S. Department of Labor pointed to a modest improvement in labour market conditions. Initial jobless claims fell by 5,000 to 227,000 for the week ended February 7, 2026, down from 232,000 previously, offering some support to the broader economic outlook.
Taking into the US market's performance over the last week, following the major global macros and data front, based on the technical analysis of the S&P/TSX Composite Index, the one TSX listed stock fit the maximum criteria on the technical framework. The recommendations are based on the generic insights, entry price, target prices, and stop-loss for Knight Therapeutics Inc. (TSX: GUD) for the next 2-4 weeks.
Knight Therapeutics Inc. (TSX: GUD)
Price Action Analysis (On the Daily Chart)
On the daily chart, GUD continues to trade above its rising trendline support, signalling sustained buying interest at current levels. The recent rebound, accompanied by improving volume, points to strengthening bullish momentum and healthier investor participation. If this positive bias persists over the next 2–4 weeks, the stock appears well positioned to retest immediate resistance near CAD 7.05. A decisive break above CAD 7.55 would confirm continuation of the broader uptrend and open the door to further near-term upside.
Technical Analysis (On the Daily Chart)
On the daily chart, the 14-period Relative Strength Index (RSI) at 70.17 signals stabilising momentum, with scope for further upside should buying interest continue to strengthen. Weekly trading volumes remain consistently firm, reinforcing this outlook through steady investor participation and healthy market activity. Additionally, the stock continues to trade above its 21-period Simple Moving Average (SMA), which is acting as a key dynamic support.
General Recommendation:
As per the above-mentioned price action and technical analysis, Knight Therapeutics Inc. is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. Investment decisions should be made depending on an individual’s appetite for upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report. Below is the summary of our recommendation.
Upcoming Major Global Economic Events
Market events occur on a day-to-day basis depending on the frequency of the data and generally include updates on employment, inflation, GDP, consumer sentiments, etc. Noted below are the upcoming week's major global economic events that could impact the S&P/TSX Composite Index and listed stocks' prices.
Related Risks: This report may be looked at from high-risk perspective and recommendations are provided are for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.
Note 1: Individuals can consider exiting from the stock if the Target Price or Stop loss mentioned as per the technical analysis has been achieved and subject to the factors discussed above.
Note 2: How to Read the Charts?
The Green color line reflects the 21-period moving average, while the Red color line indicates the 50-period moving average. SMA helps to identify existing price trend. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.
The Black color line in the chart's lower segment reflects the Relative Strength Index (14-Period), which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status, while a reading of 30 or below suggests an oversold status.
The Blue color bars in the chart's lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume. Liquidity in stocks helps in easier and faster execution of the order.
The Orange color lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.
Technical Indicators Defined: -
Key Risks: Technical indicators are backward-looking and may generate false or lagged signals, particularly during volatile or changing market conditions. Price trends may also be disrupted by fundamental, macroeconomic, or company-specific developments not captured in charts.
Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.
Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.
Stop-loss: It is a level to protect further losses in case of unfavorable movement in the stock prices.
Risk Reward Ratio: The risk reward ratio is the difference between an entry point to a stop loss and profit level. This report is based on ~80% Stop Loss of the Target 1 from the entry point.
A trailing stop-loss is a modification of stop-loss in case of favourable movement in the price to protect the gains. Individuals can Trail the Stop-Loss as per the aforementioned levels if the stock price achieves more than 50% of the Target 1. individuals should consider exiting from the position as per the Trailing Stop-Loss level if the price starts moving downwards after achieving more than 50% of the Target 1.
The reference date for all price data, currency, technical indicators, support, and resistance levels is February 13, 2026. The reference data in this report has been partly sourced from REFINITIV.
Abbreviations
CMP: Current Market Price
SMA: Simple Moving Average
CAD: Canadian Dollar
RSI: Relative Strength Index
Note: Trading decisions require a thorough analysis by individuals. Technical reports in general chart out metrics that may be assessed by individuals before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an Indicator nor a guarantee of future performance.
Past performance is not a reliable indicator of future performance.
NZ
UK
US
AU
IND
CA
Please wait processing your request...